Oxford PharmaGenesis to present pioneering data source assessment method at ISPOR
A pioneering method to identify and recommend bespoke data sources for global programmes of real-world evidence is being presented at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).
Oxford PharmaGenesis will present details of a new methodology, known as Systematic Understanding of Real-World Evidence (SURE™), that identifies observational data sources for addressing specific research questions. The process has been tested in both common and rare conditions in a range of therapeutic areas, including cardiology, diabetes, oncology and respiratory medicine.
Dr Karen Smoyer Tomic, US Practice Lead in Value Demonstration at Oxford PharmaGenesis says, “This method has enabled us to cast a global net, scrutinize a variety of potential data sources, and home in on the best data to support diverse observational research programmes. Our clients have used our recommendations to initiate research in their target regions, knowing that the necessary data will be available and accessible. In cases in which specialized data were not available, we’ve been able to connect our clients with potential collaborators for collecting the needed information”.
Karen Smoyer Tomic will be presenting ‘Identifying Real-World Data for Observational Studies: A Systematic Approach’ at ISPOR’s poster session IV, Tuesday 3 June (15:45–19:45) at C13, and will be available for discussion 18:45–19:45.